At present, the development of those solutions is hindered by slow, expensive, and overly complex lab workflows.
We are dedicated to developing a platform that integrates robotics, software, assay development, and lab operations to supercharge the pace of innovation in life sciences.
We supply sequencing services to healthcare systems and governments, offering affordable, high-throughput sequencing solutions.
We offer genome-scale cell engineering solutions for biopharma, enabling the development of novel therapeutics.
We create flexible, easy-to-use robotics to help life science labs in academia and industry automate their operations.
- Jon Brennan-BadalCEO, Opentrons Labworks, Inc.
- Eva BorattoCFO, Opentrons Labworks, Inc
- Myrtle PotterChair of the Board, Opentrons Labworks, Inc
- Robert S. LangerHead of Scientific Advisory Board, Neochromosome, Inc
- Vinod KhoslaMember of the Board, Opentrons Labworks, Inc
- Alex MorganMember of the Board, Opentrons Labworks, Inc
- Angela DuMember of the Board, Opentrons Labworks, Inc
- Eric HippeauMember of the Board, Opentrons Labworks, Inc
- Sven StrohbandMember of the Board, Opentrons Labworks, Inc
This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.
